Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 55 to 85

Knee injections for obese patients with knee arthritis

Official title: Comparison of Varying Doses of Steroid for Intra-articular Knee Injections

Run by Mayo Clinic · NCT06782529 · Data updated 2026-11-12

This study is testing whether low-dose corticosteroid injections can help obese patients with knee arthritis feel better and move easier, just like the standard-dose injections do.

Quick facts

PhasePhase 4
Study typeInterventional
Ages55 Years to 85 Years
SexAll
Enrollment40 (estimated)
SponsorMayo Clinic
Academic / other
Locations1 site (Jacksonville, Florida)
StatusRecruiting
StartedJanuary 24, 2025
Main results expectedJanuary 24, 2027
Study endsJanuary 24, 2027
Registry record updatedMarch 10, 2026
Trial IDNCT06782529 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are obese patients with a BMI of 30 kg/m2 or higher who have been diagnosed with knee osteoarthritis.

Probably not a fit

Patients with a BMI below 30 kg/m2 or those with uncontrolled diabetes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of low-dose versus standard-dose corticosteroid injections in obese patients suffering from knee osteoarthritis. It aims to determine whether the low-dose treatment is non-inferior in improving pain and function compared to the standard dose. The study will involve patients with a body mass index (BMI) of 30 kg/m2 or higher who have radiographic evidence of knee osteoarthritis and are seeking steroid injections. Participants will be monitored for changes in knee pain and functional outcomes following treatment.

Why it matters

Potential benefit: If successful, this study could provide a safer and equally effective treatment option for obese patients with knee arthritis.

How similar studies have gone: Other studies have shown promising results with corticosteroid injections for knee osteoarthritis, but this specific comparison of low-dose versus standard-dose in obese patients is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

• Patients with BMI ≥30 kg/m2 and radiograph-proven knee osteoarthritis who are interested in receiving a steroid injection for knee arthritis.

Exclusion Criteria:

* BMI \< 30 kg/m2
* Uncontrolled diabetics with a hemoglobin A1c \> 8%
* No other treatment within the time frame of the study.
* Patients that are undergoing physical therapy at the time of the study.

Where it's running

  • Mayo Clinic in Florida
    Jacksonville, Florida, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.